Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Cost and Effectiveness in the First-line Treatment of Advanced Renal Cell Cancer With Sunitinib Compared to Interferon-alfa in Finland.

NCT00980213 is registered in ClinicalTrials.gov with Pirkko-Liisa Kellokumpu-Lehtinen as lead sponsor.

NCT NCT00980213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00980213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Cost and Effectiveness in the First-line Treatment of Advanced Renal Cell Cancer With Sunitinib Compared to Interferon-alfa in Finland.
Lead sponsor
Pirkko-Liisa Kellokumpu-Lehtinen
Phase
Observational
Overall status
Completed
Start date
September 30, 2009
Completion date
December 31, 2013
Enrollment
80 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms, renal cell carcinoma